Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.
J Clin Oncol. 2009 Jan 20; 27(3):398-403
Laurence Klotz
23 Jul 2012
|
New Finding
This recent overview concluded that prostate-specific antigen (PSA) kinetics, although predictive, did not add predictive value to absolute PSA values, and should not be used for decision-making in localized prostate cancer.
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.